首页 | 本学科首页   官方微博 | 高级检索  
检索        

大黄素诱导自噬改善顺铂导致肾小管细胞损伤机制探索
引用本文:刘红,孙伟,顾刘宝.大黄素诱导自噬改善顺铂导致肾小管细胞损伤机制探索[J].世界科学技术-中医药现代化,2017,19(3):529-535.
作者姓名:刘红  孙伟  顾刘宝
作者单位:武汉市第一医院 武汉 430022,江苏省中医院南京中医药大学附属医院 南京 210029,江苏省省级机关医院江苏省老年医学研究所 南京 210024
基金项目:江苏省普通高校研究生科研创新计划项目(SJLX15_0445):大黄素通过自噬途径对顺铂致NRK-52E细胞损害的保护及其机制研究,负责人:刘红;国家自然科学基金委面上项目(81373607):基于调控PI3K/Akt通路的大黄附子汤保护肾小管上皮细胞凋亡的研究,负责人:孙伟;江苏省科技厅科技创新与成果转化(生命健康科技)专项资金(BL2012032):基于“肾虚湿瘀”理论延缓慢性肾脏病(CKD3期)进展中西医优化方案研究及推广应用,负责人:孙伟。
摘    要:目的:观察大黄素对顺铂所致的肾小管上皮细胞(NRK-52E)损伤的影响,探讨其可能分子调节机制。方法:观察大黄素对顺铂所致NRK-52E细胞形态学改变的影响;采用Western Blot方法检测顺铂单独处理和加入大黄素共同处理细胞后,凋亡相关蛋白Caspase-3和cleaved Caspase-3的表达情况;用大黄素干预细胞不同的时间点,观察微管相关蛋白1轻链3(LC3)II/I的表达和pmRFP-LC3质粒转染细胞后荧光颗粒的变化情况,同时观察雷帕霉素处理细胞不同时间点后LC3-II/I的表达情况及其对顺铂环境下细胞形态学改变的影响,并观察大黄素对自噬上游通路AMPK的活化和mTOR信号的影响。结果:顺铂可以诱导NRK-52E细胞出现形态学改变,大黄素能够改善顺铂导致的变化。另外,大黄素干预可以下调顺铂导致的cleaved Caspase-3蛋白表达的增多;大黄素处理细胞不同时间点LC3-II/LC3-I的比值明显上升,pmRFP-LC3转染观察到大黄素处理细胞后自噬颗粒明显增多。同时雷帕霉素处理细胞后LC3-II/LC3-I的比值明显上升,其与顺铂共同干预能明显改善顺铂诱导的细胞凋亡;大黄素干预时间的延长,p-mTOR蛋白表达明显下调,p-AMPK的表达明显上调。结论:大黄素可以改善顺铂诱导的NRK-52E细胞凋亡,其作用机制可能是通过调节AMPK/mTOR信号通路诱导自噬来发挥肾保护作用。

关 键 词:大黄素  顺铂  自噬  凋亡  肾小管上皮细胞
收稿时间:2016/10/17 0:00:00
修稿时间:2017/2/25 0:00:00

Mechanism Exploration on Emodin Ameliorates Cisplatin-induced Renal Tubular Cell Injury through Activation of Autophagy
Liu Hong,Sun Wei and Gu Liubao.Mechanism Exploration on Emodin Ameliorates Cisplatin-induced Renal Tubular Cell Injury through Activation of Autophagy[J].World Science and Technology-Modernization of Traditional Chinese Medicine,2017,19(3):529-535.
Authors:Liu Hong  Sun Wei and Gu Liubao
Institution:Wuhan No.1 Hospital, Wuhan 430022, China,Jiangsu Provincial Hospital of Traditional Chinese Medicine, Affiliated Hospital of Nanjing University of Traditional Chinese Medicine, Nanjing 210029, China and Hospital of the Provincial Organization, Jiangsu Province Institute of Geriatrics, Nanjing 210024, China
Abstract:This study was aimed to observe the effect of emodin on cisplatin-induced renal tubular epithelial cells (NRK- 52E) injury, in order to explore its possible molecular mechanisms. Firstly, effects of emodin on cisplatin- induced morphological changes in NRK-52E cells were observed. Secondly, the apoptosis-related protein expression of Caspase- 3 and cleaved Caspase-3 were detected after the treatment of cisplatin alone or cisplatin together with emodin by western blot. Then, the expression of microtubule-associated protein 1 light chain 3 (LC3) II/I was detected after the treatment of emodin or rapamycin at different time points by western blot. Changes of pmRFP- LC3 fluorescent particles were observed by fluorescence microscopy. And effects of rapamycin on cellular morphological changes were observed in the environment of cisplatin. Finally, effects of emodin on the activation of AMPK and mTOR signal pathway were further observed, which is considered as the upstream of autophagy signaling pathway. The results showed that cisplatin can induce morphological changes in NRK- 52E cell, which was obviously ameliorated by the intervention of emodin. Additionally, the increased protein expression of cleaved Caspase-3 induced by cisplatin was obviously reduced after the intervention of emodin. The LC3-II/LC3-I ratio was significantly increased after the treatment of emodin or rapamycin at different time points. Rapamycin can significantly ameliorate NRK- 52E cell apoptosis induced by cisplatin. Simultaneously, the number of pmRFP- LC3 fluorescent particles increased after the treatment of emodin. As the extension of time by intervention of emodin, the protein expression of p-mTOR was significantly reduced. In contrast, the protein expression of p- AMPK was significantly increased. It was concluded that emodin can ameliorate cisplatininduced apoptosis in NRK- 52E cells. Its potential mechanism may be attributed to the activation of autophagy by regulating AMPK/mTOR signaling pathway. And thus, it played a role in renal protective effects.
Keywords:
点击此处可从《世界科学技术-中医药现代化》浏览原始摘要信息
点击此处可从《世界科学技术-中医药现代化》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号